The growth in Artificial Intelligence (AI) technology integration is increasing rapidly in various sectors. A lot of startups across the world are creating new approaches and seeking innovative business models in a bid to disrupt the pharmaceutical industry.
As per a report, the global artificial intelligence (AI) in the drug discovery market is expected to grow from $1.60B (approx €1.3B) in 2019 to $40.36B (approx €34.55B) by 2027, at a CAGR of 49.6% during the forecast period 2020-2027.